Chemical Works of Gedeon Richter (OTCPK:RGEDF) Price-to-Owner-Earnings

: 13.38 (As of Today)

View and export this data going back to 2007. Start your Free Trial

As of today (2023-03-23), Chemical Works of Gedeon Richter's share price is $19.80. Chemical Works of Gedeon Richter's Owner Earnings per Share (TTM) ended in Sep. 2022 was $1.48. It's Price-to-Owner-Earnings for today is 13.38.

The historical rank and industry rank for Chemical Works of Gedeon Richter's Price-to-Owner-Earnings or its related term are showing as below:

RGEDF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.4 Med: 22.7 Max: 566.94
Current: 13.38

During the past 13 years, the highest Price-to-Owner-Earnings of Chemical Works of Gedeon Richter was 566.94. The lowest was 9.40. And the median was 22.70.

RGEDF's Price-to-Owner-Earnings is ranked better than
70.45% of 423 companies
in the Drug Manufacturers industry
Industry Median: 22.33 vs RGEDF: 13.38

As of today (2023-03-23), Chemical Works of Gedeon Richter's share price is $19.80. Chemical Works of Gedeon Richter's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 was $3.49. Therefore, Chemical Works of Gedeon Richter's PE Ratio for today is 5.68.

As of today (2023-03-23), Chemical Works of Gedeon Richter's share price is $19.80. Chemical Works of Gedeon Richter's EPS without NRI for the trailing twelve months (TTM) ended in was $3.49. Therefore, Chemical Works of Gedeon Richter's PE Ratio without NRI for today is 5.68.

During the past 13 years, Chemical Works of Gedeon Richter's highest PE Ratio without NRI was 353.75. The lowest was 5.61. And the median was 18.88.

Chemical Works of Gedeon Richter Price-to-Owner-Earnings Historical Data

The historical data trend for Chemical Works of Gedeon Richter's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Price-to-Owner-Earnings

300.00

29.46

51.03

17.38

20.18

Chemical Works of Gedeon Richter Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Price-to-Owner-Earnings																31.31	20.18	13.67	14.81	13.59

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Chemical Works of Gedeon Richter Price-to-Owner-Earnings Distribution

For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Chemical Works of Gedeon Richter's Price-to-Owner-Earnings falls in comparison to its industry or sector. The grey bar indicates the Price-to-Owner-Earnings's extreme value range as defined by GuruFocus.

Chemical Works of Gedeon Richter Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Chemical Works of Gedeon Richter's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	19.80	/	1.48
	=	13.38

Chemical Works of Gedeon Richter (OTCPK:RGEDF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

Chemical Works of Gedeon Richter Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Chemical Works of Gedeon Richter's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

Chemical Works of Gedeon Richter (OTCPK:RGEDF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (OTCPK:RGEDF) » Definitions » Price-to-Owner-Earnings

Traded in Other Exchanges

GEDSF:USA RICHTER:Hungary 0QFP:UK RIG2:Germany

Address

Gyomroi ut 19-21, Budapest, HUN, 1103

Website

https://www.richter.hu

Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two major business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.

Chemical Works of Gedeon Richter (OTCPK:RGEDF) Headlines

From GuruFocus

Brandes Investment Trust Comments on Chemical Works of Gedeon Richter

By 12-04-2015